3D screening system to cultivate tissue and automatically stimulate and quantify its mechanical properties
The project aims to develop the TissMec system for automated 3D human tissue creation and screening to expedite drug candidate evaluation and improve the drug development process.
Projectdetails
Introduction
The way from potential drug candidates to clinically approved new medication is long and expensive. To improve this, we will provide the TissMec system that can create 3D human tissue while providing an automated and scalable way to quantify potential problems of drugs and other compounds of interest.
System Capabilities
Our TissMec system can not only measure the force generation of muscles and other contractile tissue but also continuously determine the viscoelastic tissue properties while mimicking mechanical situations that are known hallmarks of several critical diseases.
Current Limitations
Up to now, obtaining such information is either not possible or requires slow and expensive manual work. Hence, an automated, scalable, and standardized (96 well) system that can quickly screen properties on human tissue can become a game-changer, as it identifies problematic drugs and compounds very early in the drug development process.
Project Development
We have a laboratory prototype (TRL4) that already demonstrates these capacities, and the proposed PoC project will develop this lab version into a user-friendly TRL6 prototype that we can give to our partners in pharmacology and toxicology and to already well-established industry partners.
Team Composition
Our team is composed of 5 scientists spanning:
- Physics
- Biology
- Chemistry
- Data Science
- Economy
Hence, we not only have invented a new technology to greatly improve an urgent current problem but also have a powerful network and outstanding team to ensure the success of our project.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-3-2024 |
Einddatum | 31-8-2025 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- GEORG-AUGUST-UNIVERSITAT GOTTINGEN STIFTUNG OFFENTLICHEN RECHTSpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological TestingISBIOMECH aims to develop a novel intelligent system for controlling mechanical environments in biological testing, enhancing in-vitro therapies and drug discovery for various pathologies. | ERC Proof of... | € 150.000 | 2023 | Details |
Engineering soft microdevices for the mechanical characterization and stimulation of microtissuesThis project aims to advance mechanobiology by developing soft robotic micro-devices to study and manipulate 3D tissue responses, enhancing understanding of cell behavior and potential cancer treatments. | ERC Advanced... | € 3.475.660 | 2025 | Details |
Development of a high-throughput microplate based device to analyse the patient derived tumour microenvironment3DTUMOUR aims to enhance drug development success by providing patient-specific 3D bioprinted tumour models for ex vivo testing, improving treatment efficacy and reducing toxicity in cancer therapy. | ERC Proof of... | € 150.000 | 2024 | Details |
A new device to analyse the regional variations of mechanical properties in cells and tissues: prototyping and assessment of commercial potential for drug discovery applicationsThe MECHANOMICS-POC project aims to develop and commercialize a novel multimodal technology for measuring mechanical properties in biological tissues, enhancing drug discovery and diagnostics. | ERC Proof of... | € 150.000 | 2022 | Details |
INhibiting mechanoTRansduction as a novel approach for Oncology theraPY (INTROPY)This project aims to develop a first-in-class mechanoinhibitor drug targeting stiffness-induced protein unfolding in solid tumors, with potential applications in cancer therapy and fibrosis. | ERC Proof of... | € 150.000 | 2025 | Details |
Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological Testing
ISBIOMECH aims to develop a novel intelligent system for controlling mechanical environments in biological testing, enhancing in-vitro therapies and drug discovery for various pathologies.
Engineering soft microdevices for the mechanical characterization and stimulation of microtissues
This project aims to advance mechanobiology by developing soft robotic micro-devices to study and manipulate 3D tissue responses, enhancing understanding of cell behavior and potential cancer treatments.
Development of a high-throughput microplate based device to analyse the patient derived tumour microenvironment
3DTUMOUR aims to enhance drug development success by providing patient-specific 3D bioprinted tumour models for ex vivo testing, improving treatment efficacy and reducing toxicity in cancer therapy.
A new device to analyse the regional variations of mechanical properties in cells and tissues: prototyping and assessment of commercial potential for drug discovery applications
The MECHANOMICS-POC project aims to develop and commercialize a novel multimodal technology for measuring mechanical properties in biological tissues, enhancing drug discovery and diagnostics.
INhibiting mechanoTRansduction as a novel approach for Oncology theraPY (INTROPY)
This project aims to develop a first-in-class mechanoinhibitor drug targeting stiffness-induced protein unfolding in solid tumors, with potential applications in cancer therapy and fibrosis.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Mera - Ethical, accurate drug developmentThe Mera system automates the culture, drugging, and staining of 3D tissues on a large scale, enabling real-time monitoring and modular scalability for diverse tissue types. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Slim labinstrument voor 3D celculturenIMcoMET onderzoekt de ontwikkeling van een kosteneffectief labinstrument voor continue, niet-destructieve metingen van fysiologische parameters in 3D-celculturen voor geneesmiddelonderzoek. | Mkb-innovati... | € 20.000 | 2021 | Details |
Bringing 3D cardiac tissues to high throughput for drug discovery screensDeveloping a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability. | EIC Transition | € 1.457.500 | 2023 | Details |
IDEFIX Multiorgan toxicity and efficacy test platformCherry Biotech's IDEFIX project aims to revolutionize preclinical drug testing by developing a customizable organ-on-chip platform that mimics human multiorgan physiology, enhancing efficacy and toxicity predictions. | EIC Transition | € 2.496.073 | 2022 | Details |
High Throughput Cell contractility system for rapid drug evaluationCytocypher en Optics11 ontwikkelen samen een prototype van een high throughput screening systeem voor het functioneel meten van hartspiercellen, ter bevordering van cardiologisch onderzoek. | Mkb-innovati... | € 193.900 | 2015 | Details |
Mera - Ethical, accurate drug development
The Mera system automates the culture, drugging, and staining of 3D tissues on a large scale, enabling real-time monitoring and modular scalability for diverse tissue types.
Slim labinstrument voor 3D celculturen
IMcoMET onderzoekt de ontwikkeling van een kosteneffectief labinstrument voor continue, niet-destructieve metingen van fysiologische parameters in 3D-celculturen voor geneesmiddelonderzoek.
Bringing 3D cardiac tissues to high throughput for drug discovery screens
Developing a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability.
IDEFIX Multiorgan toxicity and efficacy test platform
Cherry Biotech's IDEFIX project aims to revolutionize preclinical drug testing by developing a customizable organ-on-chip platform that mimics human multiorgan physiology, enhancing efficacy and toxicity predictions.
High Throughput Cell contractility system for rapid drug evaluation
Cytocypher en Optics11 ontwikkelen samen een prototype van een high throughput screening systeem voor het functioneel meten van hartspiercellen, ter bevordering van cardiologisch onderzoek.